Omnipod 5 System Sustains Glycemic Benefits Through 12 MonthsByAshley Gallagher, MASeptember 11th 2026
The Pharmacist’s Role Amid Measles Surge, Vaccine Policy ChangeByBrian Nowosielski,Thomas Lew, MD, ABIM,Molly O’Shea, MD, FAAP,Jesse Goodman, MD, MPHSeptember 10th 2026
Model Finds Weight Regain After Stopping Semaglutide or TirzepatideByAshley Gallagher, MASeptember 10th 2026
Investigational Oral AD109 Reduces Sleep Apnea Severity by 44%ByAshley Gallagher, MASeptember 10th 2026
Measles Resurgence Exposes US Vaccine Policy Risks, Experts WarnByBrian Nowosielski,Jesse Goodman, MD, MPHSeptember 9th 2026